Advances in Clinical Medicine, Journal Year: 2024, Volume and Issue: 14(08), P. 34 - 40
Published: Jan. 1, 2024
Language: Английский
Advances in Clinical Medicine, Journal Year: 2024, Volume and Issue: 14(08), P. 34 - 40
Published: Jan. 1, 2024
Language: Английский
Pharmacological Research, Journal Year: 2024, Volume and Issue: unknown, P. 107419 - 107419
Published: Sept. 1, 2024
Language: Английский
Citations
4Frontiers in Immunology, Journal Year: 2024, Volume and Issue: 15
Published: Oct. 21, 2024
In recent years, cancer, especially primary liver cancer (including hepatocellular carcinoma and intrahepatic cholangiocarcinoma), has posed a serious threat to human health. the field of exosomes play an important role in initiation, metastasis interaction with tumor microenvironment. Exosomes are class nanoscale extracellular vesicles (EVs)secreted by most cells rich bioactive molecules, including RNA, proteins lipids, that mediate intercellular communication during physiological pathological processes. This review reviews multiple roles progression, as well their effects on angiogenesis, epithelial-mesenchymal transformation (EMT), immune evasion, drug resistance. have great potential biomarkers for diagnosis prognosis because they carry specific molecular markers facilitate early detection evaluation treatment outcomes. addition, exosomes, new type delivery vector, unique advantages targeted therapy provide strategy cancer. The challenges prospects exosome-based immunotherapy were also discussed. However, such standardization isolation techniques scalability therapeutic applications remain significant hurdles.
Language: Английский
Citations
3Cellular Oncology, Journal Year: 2025, Volume and Issue: unknown
Published: Feb. 10, 2025
Language: Английский
Citations
0Stem Cell Reviews and Reports, Journal Year: 2025, Volume and Issue: unknown
Published: March 17, 2025
Language: Английский
Citations
0Journal of Biological Chemistry, Journal Year: 2025, Volume and Issue: unknown, P. 108528 - 108528
Published: April 1, 2025
Protein homeostasis is primarily regulated by post-translational modifications (PTMs). HIPK3 has been recognized as a tumor suppressor across various cancers. However, the impact of PTMs on remains insufficiently explored. This study identified WWP1 an E3 ubiquitin ligase targeting HIPK3, demonstrating that downregulates protein levels facilitating its ubiquitination. Mechanistically, directly interacts with promoting K48-linked polyubiquitination at K1187 site. The WWP1/HIPK3 axis modulates cancer cell chemosensitivity through regulation JNK signaling pathway. Additionally, Myc was found to act transcription factor, enhancing expression. These findings offer novel insights into PTM level.
Language: Английский
Citations
0Mitochondrion, Journal Year: 2025, Volume and Issue: 84, P. 102045 - 102045
Published: April 24, 2025
Language: Английский
Citations
0Frontiers in Cell and Developmental Biology, Journal Year: 2025, Volume and Issue: 13
Published: May 14, 2025
Hepatoblastoma (HB), the most common pediatric liver malignancy, is characterized by aggressive growth and metastasis driven complex angiogenic mechanisms. This review elucidates pivotal role of angiogenesis in HB progression, emphasizing metabolic reprogramming, tumor microenvironment (TME) dynamics, oncogenic signalling pathways. The Warburg effect cells fosters a hypoxic microenvironment, stabilizing hypoxia-inducible factor-1α (HIF-1α) upregulating vascular endothelial factor (VEGF), which synergistically enhances angiogenesis. Key pathways such as Wnt/β-catenin, VEGF, PI3K/AKT, JAK2/STAT3 are central to cell proliferation, migration, maturation, whereas interactions with tumor-associated macrophages (TAMs) pericytes further remodel TME support neovascularization. Long noncoding RNAs glycolytic enzymes have emerged critical regulators angiogenesis, linking activity expansion. Anti-angiogenic therapies, including VEGF inhibitors pathway-targeting agents, show preclinical promise but face challenges resistance off-target effects. Future directions advocate for dual-target strategies, spatial multiomics technologies map metabolic–angiogenic crosstalk, personalized approaches leveraging biomarkers risk stratification. synthesis underscores need interdisciplinary collaboration translate mechanistic insights into durable ultimately improving outcomes patients.
Language: Английский
Citations
0Cell Death Discovery, Journal Year: 2025, Volume and Issue: 11(1)
Published: May 17, 2025
This study aims to explore the molecules that affect survival of Human Umbilical Vein Endothelial Cells (HUVECs) under hypoxia and their mechanisms action. In hypoxia, plasmolipin (PLLP) was identified through screening CRISPR/Cas9 small guide RNA (sgRNA) library. Functionally, PLLP knockout led increase cell proliferation, cellular metabolism, tight junction formation, angiogenesis ability, migration invasion in hypoxic HUVECs. Furthermore, countered inhibitory effects bevacizumab on HUVECs conditions. found modulate by enhancing phosphorylation AKT ERK1/2 proteins. conclusion, inhibiting expression promotes maintenance functions condition. plays a crucial role regulating activation pathways. identifies novel conditions provides new possibility for future studies
Language: Английский
Citations
0Stem Cell Reviews and Reports, Journal Year: 2025, Volume and Issue: unknown
Published: May 24, 2025
Language: Английский
Citations
0Frontiers in Bioscience-Landmark, Journal Year: 2024, Volume and Issue: 29(5)
Published: May 15, 2024
Background: It has been demonstrated that exosomes derived from HPV-16 E7-over-expressiong non-small cell lung cancer (NSCLC) cells (E7 Exo) trigger increased levels of epidermal growth factor receptor (EGFR) and miR-381-3p. The purpose this investigation was to examine the role E7 Exo in NSCLC angiogenesis, analyze contribution exosomal EGFR miR-381-3p it. Methods: influence on proliferation migration human umbilical vein endothelial (HUVECs) assessed using colony formation transwell assays. Experiments both animal models were conducted evaluate angiogenic effect treatment. involvement angiogenesis further investigated through suppressing exosome release or activation, by over-expressing Results: Treatment with proliferation, migration, tube capacities HUVECs, as well models. suppression activation decreased E7-induced enhancements HUVEC formation, notably reduced vascular A (VEGFA) Ang-1 levels. HUVECs combined mimic transfection treatment exhibited a more significant tube-forming capacity than Exo-treated alone, but reversed inhibitor. Conclusion: induced is mediated
Language: Английский
Citations
2